Collectively, these studies suggest that the AnxA1/FPR2 axis could be a potential target for host-directed therapies for arbovirus-induced infections, such as CHIKV, DENV, and ZIKV, due to its protective role in these diseases. The gene discussed is ANXA1; the disease is infection.